Minireview: Nomenclature and Classification of Transmitter Receptors: an Integrated Approach

References

• Mills A., Duggan M. J. Orphan seven transmembrane domain receptors: reversing pharmacology. Trends Pharmacol. Sci. 1993; 14: 394–396
   PubMed Web of Science ®Google Scholar
• Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995; 377: 532–534
   PubMed Web of Science ®Google Scholar
• Bylund D. B., Eikenberg D. C., Hieble J. P., Langer S. Z., Lefkowitz R. J., Minneman K. P., Molinoff P. B., Ruffolo R. R., Trendelenburg U., IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 1994; 46: 121–136
   PubMed Web of Science ®Google Scholar
• Coleman R. A., Smith W. L., Narumiya S., VIII. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol. Rev. 1994; 46: 205–229
   PubMed Web of Science ®Google Scholar
• Fredholm B. B., Abbracchio M. P., Burnstock G., Daly J. W., Harden T. K., Jacobson K. A., Leff P., Williams M., VI. International Union of Pharmacology nomenclature and classification of purinoceptors. Pharmacol. Rev. 1994; 46: 143–156
   PubMed Web of Science ®Google Scholar
• Hoyer D., Clarke D. E., Fozard J. R., Hartig P. R., Martin G. R., Mylecharane E. J., Saxena P. R., Humphrey P. P. A., VII. International Union of Pharmacology classification of receptors for 5-Hydroxytryptamine (serotonin). Pharmacol. Rev. 1994; 46: 157–203
   PubMed Web of Science ®Google Scholar
• Kenakin T. P., Bond R. A., Bonner T. I. Definition of pharmacological receptors. Pharmacol. Rev. 1992; 44: 351–362
   PubMed Web of Science ®Google Scholar
• Humphrey P. P. A., Hartig P. R., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 1993; 14: 233–236
   PubMed Web of Science ®Google Scholar
• Humphrey P. P. A., Spedding M., Vanhoutte P. M. Receptor classification and nomenclature: the revolution and the resolution. Trends Pharmacol. Sci. 1994; 15: 203–204
   PubMed Web of Science ®Google Scholar
• Vanhoutte P. M., Humphrey P. P. A., Spedding M. Recommendations for nomenclature of new receptor subtypes. Pharmacol. Rev. 1996; 48: 1–2
   PubMed Web of Science ®Google Scholar
• Stephenson R. P. Interaction of agonists and antagonists with their receptors. INSERM 1975; 50: 15–28
   Google Scholar
• Trends Pharmacol. Sci. Receptor and channel nomenclature supplements. March, 1994, 1995, 1996
   Google Scholar
• Hoyer D. Biochemical mechanisms of 5-HT receptor-effector coupling in peripheral tissues. Peripheral actions of 5-HT, J. R. Fozard. Oxford University Press. 1989; 72–99
   Google Scholar
• Jenkinson D. H., Barnard E. A., Hoyer D., Humphrey P. P. A., Leff P., Shankley N. P. Recommendations on terms and symbols in quantitative Pharmacology. Pharmacol Rev 1995; 47: 255–266
   PubMed Web of Science ®Google Scholar
• Gether U., Johansen T. E., Snider R. M., Lowe J. A., Nakanishi S., Schwartz T. W. Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist. Nature 1993; 362: 345–347
   PubMed Web of Science ®Google Scholar
• Schwartz T. W. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotech. 1994; 5: 434–444
   PubMedGoogle Scholar
• Frielle T., Daniel K. W., Caron M. G., Lefkowitz R. J. The structural basis of β-adrenergic receptor subtype specificity: studies with chimeric β1/β2-adrenergic receptor. Proc. Nat. Acad. Sci. 1988; 85: 9494–9498
   PubMed Web of Science ®Google Scholar
• Regoli D., Boudon A., Fauchere J.-C. Receptors and antagonists for substance P and related peptides. Pharmacol. Rev. 1994; 46: 551–599
   PubMed Web of Science ®Google Scholar
• Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B., Seeburg P. H. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 1992; 256: 1217–1221
   PubMed Web of Science ®Google Scholar
• Black J. W., Stephenson J. S. Pharmacology of a new adrenergic β-receptor blocking compound. Lancet 1962; 2: 311–314
   PubMed Web of Science ®Google Scholar
• Black J. W., Duncan W. A. M., Durant C. J., Ganellin C. R., Parsons E. M. Definition and antagonism of histamine H2-receptors. Nature 1972; 236: 385–390
   PubMed Web of Science ®Google Scholar
• Ash A. S. F., Schild H. O. Receptors mediating some actions of histamine. Br. J. Pharmacol. 1966; 27: 427–439
   PubMed Web of Science ®Google Scholar
• Ahlquist R. P. A study of the adrenergic receptors. Am. J. Physiol. 1948; 153: 586–600
   PubMed Web of Science ®Google Scholar
• Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr. Differentiation of receptor systems activated by sympathomimetic amines. Nature 1967; 214: 597–598
   PubMed Web of Science ®Google Scholar
• Doxey J. C., Smith C. F. C., Walker J. M. Selectivity of blocking agents for pre- and postsynaptic α-adrenoceptors. Br. J. Pharmacol. 1977; 60: 91
   PubMed Web of Science ®Google Scholar
• Hartig P. R., Hoyer D., Humphrey P. P. A., Martin G. R. Alignment of receptor nomenclature with the human genome. Effects on classification of 5-HT1B/5-HT1D receptor subtypes. Trends Pharmacol. Sci. 1996; 17: 103–105
   PubMed Web of Science ®Google Scholar
• Bradley P. B., Engel G., Feniuk W., Fozard J. R., Humphrey P. P. A., Middlemiss D. N., Mylecharane E. J., Richardson B. P., Saxena P. R. Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacol. 1986; 25: 563–576
   PubMed Web of Science ®Google Scholar
• Hoyer D. Molecular pharmacology and biology of 5-HT1C receptors. Trends Pharmacol. Sci. 1988; 9: 89–94
   PubMed Web of Science ®Google Scholar
• Hartig P. R., Branchek T. A., Weinshank R. L. A subfamily of 5-HT1D receptor genes. Trends Pharmacol. Sci. 1992; 13: 152–159
   PubMed Web of Science ®Google Scholar
• Hoyer D., Boddeke H. G. W. M. Antagonists, agonists, partial agonists: Dilemmas of definition. Trends Pharmacol. Sci 1993; 14: 270–275
   PubMed Web of Science ®Google Scholar
• Kenakin T. Agonist-receptor efficacy I: mechanisms of efficacy and receptor promiscuity. Trends Pharmacol. Sci. 1995; 16: 188–192
   PubMed Web of Science ®Google Scholar
• Kenakin T. Agonist-receptor efficacy II: agonist trafficking of receptor signals. Trends Pharmacol. Sci. 1995; 16: 232–238
   PubMed Web of Science ®Google Scholar
• Milligan G. Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 1993; 14: 239–244
   PubMed Web of Science ®Google Scholar
• Offermanns S., Wieland T., Homann D., Sandmann J., Bombien E., Spicher K., Schultz G., Jakobs K. H. Transfected muscarinic acetylcholine receptors selectively couple to Gi-type G proteins and Gq/11. Mol. Pharmacol. 1994; 45: 890–898
   PubMed Web of Science ®Google Scholar
• Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P. H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993; 365: 170–175
   PubMed Web of Science ®Google Scholar
• Vallar L., Muca C., Magni M., Albert P., Bunzow J., Meldolesi J., Civelli O. Differential coupling of dopaminergic D2 receptors expressed in different cell types. J. Biol. Chem. 1990; 265: 10320–10326
   PubMed Web of Science ®Google Scholar
• Kleuss C., Hescheler J., Ewel C., Rosenthal W., Schultz G., Wittig B. Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents. Nature 1991; 353: 43–48
   PubMed Web of Science ®Google Scholar
• Kleuss C., Scherübl H., Hescheler J., Schultz G., Wittig B. Different ß-subunits determine G-protein interaction with transmembrane receptors. Nature 1992; 358: 424–426
   PubMed Web of Science ®Google Scholar
• Kleuss C., Scherubl H., Hescheler J., Schultz G., Wittig B. Selectivity in signal transduction determined by gamma subunits of heterotrimeric G proteins. Science 1993; 259: 832–834
   PubMed Web of Science ®Google Scholar
• Hoyer D., Lübbert H., Bruns C. Molecular Pharmacology of somatostatin receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1994; 350: 441–453
   Google Scholar
• Hoyer D., Bell G. I., Berelowitz M., Epelbaum J., Feniuk W., Humphrey P. P. A., O'Carroll A. M., Patel Y. C., Schonbrunn A., Taylor J. E., Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol Sci. 1995; 16: 86–88
   PubMed Web of Science ®Google Scholar
• Dohlman H., Caron M., Lefkowitz R. J. A family of receptors coupled to guanine nucleotide regulating proteins. Biochem. 1987; 26: 2657–2664
   PubMed Web of Science ®Google Scholar
• Saudou F., Hen R. 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates. Neurochem. Int. 1994; 25: 503–532
   PubMed Web of Science ®Google Scholar
• Gerald C., Adham N., Kao H.-T., Olsen M. A., Laz T. M., Schechter L. E., Bard J. A., Vaysse P. J.-J., Hartig P. R., Branchek T. A., Weinshank R. L. The 5-HT4 receptor: molecular cloning and pharmacological characterization of two splice variants. EMBO J. 1995; 14: 2806–2815
   PubMed Web of Science ®Google Scholar
• Hoyer D., Middlemiss D. N. The pharmacology of the terminal 5-HT autoreceptors in mammalian brain: evidence for species differences. Trends Pharmacol. Sci. 1989; 10: 130–132
   PubMed Web of Science ®Google Scholar
• Adham N., Tamm J. A., Salon J. A., Vaysse P. J.-J., Weinshank R. L., Branchek T. A. A single point mutation increases the affinity of serotonin 5-HT1Dα, 5-HT1Dβ, 5-HT1E and 5-HT1F receptors for β-adrenergic antagonists. Neuropharmacol. 1994; 33: 387–391
   PubMed Web of Science ®Google Scholar
• Oksenberg D., Marsters S. A., O'Dowd B. F., Jin H., Havlik S., Peroutka S. J., Ashkenazi A. A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors. Nature 1992; 360: 161–163
   PubMed Web of Science ®Google Scholar
• Sachais B. S., Snider R. M., Lowe J. A., III, Krause J. E. Molecular basis for the species selectivity of the substance P antagonist CP-96,345. J. Biol. Chem. 1993; 268: 2319–2323
   PubMed Web of Science ®Google Scholar
• Hall J. M., Caulfield M. P., Watson S. P., Guard S. Receptor subtypes or species homologues: relevance to drug discovsry. Trends Pharmacol. Sci. 1993; 14: 376–383
   PubMed Web of Science ®Google Scholar